CNMD FY 2013 Earnings Report — CONMED Corporation Revenue & Financial Results | Market Cap Arena

CONMED CorporationCNMD

FY 2013 Earnings

Reported April 25, 2014

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2013	Prior Q	FY 2012	QoQ Change	YoY Change
Revenue	$757M	—	$767M	—	-1.4%
Op. Income	$57M	—	$65M	—	-13.3%
Gross Margin	53.7%	—	52.9%	—	0.8pp
Net Margin	4.7%	—	5.3%	—	-0.5pp
EPS (Diluted)	$1.28	—	$1.41	—	-9.2%
Free Cash Flow	$63M	—	$74M	—	-15.2%

Revenue Flow

Item	Amount
REVENUE	$757M
Cost of Revenue	$350M
GROSS PROFIT	$406M
R&D Expenses	$26M
Selling & Marketing	$0
General & Administrative	$311M
SG&A Expenses	$311M
Other Expenses	$9M
Operating Expenses	$350M
Cost & Expenses	$700M
OPERATING INCOME	$57M
Interest Income	$0
Interest Expense	$6M
Other Income/Expenses	-$6M
INCOME BEFORE TAX	$51M
Income Tax Expense	$15M
Net Income from Continuing Ops	$36M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$36M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$36M
D&A	$48M
EBIT	$56M
EBITDA	$104M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$757M
Cost of Revenue	$350M
GROSS PROFIT	$406M
R&D Expenses	$26M
Selling & Marketing	$0
General & Administrative	$311M
SG&A Expenses	$311M
Other Expenses	$9M
Operating Expenses	$350M
Cost & Expenses	$700M
OPERATING INCOME	$57M
Interest Income	$0
Interest Expense	$6M
Other Income/Expenses	-$6M
INCOME BEFORE TAX	$51M
Income Tax Expense	$15M
Net Income from Continuing Ops	$36M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$36M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$36M
D&A	$48M
EBIT	$56M
EBITDA	$104M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$36M
Depreciation & Amortization	$48M
Stock-Based Compensation	$6M
Deferred Income Tax	$7M
Other Non-Cash Items	$263.0K
Change in Working Capital	-$16M
OPERATING CASH FLOW	$81M
Capital Expenditure	-$18M
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$0
NET CASH FROM INVESTING	-$18M
Net Debt Issuance	$54M
Common Stock Repurchased	-$51M
Common Dividends Paid	-$17M
Other Financing Activities	-$18M
NET CASH FROM FINANCING	-$31M
FREE CASH FLOW	$63M
Net Change in Cash	$31M

Balance Sheet

Item	Amount
Cash & Equivalents	$54M
Short-Term Investments	$0
Net Receivables	$144M
Inventory	$143M
Other Current Assets	$13M
TOTAL CURRENT ASSETS	$372M
PP&E (Net)	$139M
Goodwill	$248M
Intangible Assets	$319M
Long-Term Investments	$0
Tax Assets	$1M
Other Non-Current Assets	$10M
TOTAL NON-CURRENT ASSETS	$718M
TOTAL ASSETS	$1.1B
Account Payables	$27M
Short-Term Debt	$1M
Deferred Revenue	-$27M
Other Current Liabilities	$49M
TOTAL CURRENT LIABILITIES	$111M
Long-Term Debt	$214M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$113M
Other Non-Current Liabilities	$45M
TOTAL NON-CURRENT LIABILITIES	$373M
TOTAL LIABILITIES	$484M
Common Stock	$228M
Additional Paid-In Capital	$326M
Retained Earnings	$396M
Treasury Stock	-$99M
Accum. Other Comp. Income	-$18M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$606M
Minority Interest	$0
TOTAL EQUITY	$606M
TOTAL LIABILITIES & EQUITY	$1.1B
Total Debt	$216M
Net Debt	$161M